Movement Disorder Virtual University WE MOVE
Resource LibraryMovement Disorders
Corticobasal Degeneration

Approaches to Treatment

Unfortunately, there are no drugs or other therapies that can slow the progress of the disease, and very few that offer symptomatic relief. Tremor and myoclonus may be controlled somewhat with drugs such as clonazepam. Baclofen may help reduce rigidity somewhat. Levodopa and other dopaminergic drugs used in Parkinson's disease are rarely beneficial, but may help some CBD patients.

Physical therapy exercises may be useful to maintain range of motion of stiff joints. This may prevent pain and contracture (muscle shortening), and help maintain mobility. Occupational therapy may be used to design adaptive equipment that supports the activities of daily living, thus helping to maintain more functional independence. Speech therapy is used to improve articulation and volume.

A person with CBD will usually become immobile due to rigidity within five years of symptom onset, and may require a gastrostomy tube for feeding at some point before that. Most often, within ten years of onset, pneumonia or other bacterial infections may lead to life-threatening complications.

These review articles provide information directed to medical professionals. The journals in which they appear can usually be found in a medical library. Unfortunately, WE MOVE cannot provide copies of these articles.

  1. Clinical presentation and pharmacological therapy in corticobasal degeneration. Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Arch Neurol 1998 Jul;55(7):957-61 Abstract
  2. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Ray Chaudhuri K, D'Olhaberriague L, Pearce RK. J Neurol Neurosurg Psychiatry 1998 Feb;64(2):184-9 Abstract
All contents copyright © WE MOVE 2008. This page last modified 4/1/2008.